|Baxter Launches Arisure Closed System Transfer Device to Help Prevent Hazardous Drug Exposure and Maintain Medication Sterility|
|View printer-friendly version|
The Arisure Closed System Transfer device is designed to be easy to use with an emphasis on safety. The device includes a closed vial adapter that helps provide closed access to liquid or powder vials for reconstitution; an intravenous dry spike that helps provide closed access to an IV bag for addition and removal of a drug or solution; and a closed male Luer valve that helps provide closed transfer of a diluent or drug from a standard male Luer tip in a syringe or administration set. The Arisure Closed Male Luer locks with a simple Luer lock motion on a syringe or administration set, helping reduce the exposure of healthcare professionals to sharp needles. In addition, the Arisure Closed Male Luer components are compatible with Baxter’s ONE-LINK Needle-free IV Connector and CLEARLINK Luer Activated Valve to help create a mechanically and microbiologically closed system.
“The Arisure Closed System Transfer device helps address multiple
concerns of both healthcare professionals and patients, helping ensure
safer drug preparation, transportation, administration and disposal, and
helping reduce the risk of accidental exposure or contamination,” said
The Arisure Closed System Transfer device is the latest addition to Baxter’s broad portfolio of products designed to help enhance the safe delivery of medication across the patient continuum of care, from the pharmacy to the bedside. These products include but are not limited to pharmacy software and automation that helps promote dose preparation safety and reduce waste; the Sigma Spectrum Infusion System that includes pioneering safety features to help minimize patient risk when administering vital fluids and medications; and needle-free connector product lines that can contribute to reducing hospital infections.
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; surgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
This release includes forward-looking statements concerning the
Arisure Closed System Transfer device, including potential benefits
associated with its use (including helping to ensure safer drug
preparation, transportation, administration and disposal). The
statements are based on assumptions about many important factors,
including the following, which could cause actual results to differ
materially from those in the forward-looking statements: satisfaction of
regulatory and other requirements; actions of regulatory bodies and
other governmental authorities; product quality, manufacturing or
supply, or patient safety issues; changes in law and regulations; and
other risks identified in Baxter's most recent filing on Form 10-K and
Rx Only. For safe and proper use of this device, refer to the full Instructions for Use.
Baxter, ONE-LINK, CLEARLINK and Sigma Spectrum are
Arisure is a trademark of
Baxter International Inc.